Trial Profile
A prospective, crossover study to compare the morning and bedtime administration of Olmesartan and Azelnipine
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Nov 2016
Price :
$35
*
At a glance
- Drugs Azelnidipine (Primary) ; Olmesartan medoxomil (Primary) ; Olmesartan medoxomil/azelnidipine (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 15 Nov 2016 New trial record
- 29 Sep 2016 Results presented at the 26th Scientific Meeting of the International Society of Hypertension